How Can Diverse Genomic Approaches Improve Rare Disease Research?
Tomi Pastinen, MD, PhD
Multiomic techniques can robustly screen and identify often-missed genetic determinants of rare diseases
Microarrays
Molecular Testing in the Transfusion Medicine Laboratory
Maria Roussakis, MLT, MSc
Applying molecular techniques to transfusion medicine can help improve care for all
The D3 Array™ Is Filling the Gaps Left by NGS and qPCR
Ian Black, MsComm, MSc
PathogenDx is expanding into the clinical labs, providing low-cost multiplex testing with the D3 Array™
Building a Predictive Genomics Ecosystem to Improve Population Health and Lower Costs
Kim Caple
Clinical labs are crucial for providing patients access to precision medicine
Pros and Cons of Direct-to-Consumer Genetic Testing
Miriam Bergeret, MSc
Current DTC genetic tests can yield misleading results, but understanding a few key points can help
Multiplexing: A Better Approach to Point-of-Care Diagnostics
Today's Clinical Lab
A comparison of multiplex POC assays available for diagnostics
Cancer Lab on Chip to Enable Widespread Screening, Personalized Treatment
American Institute of Physics
Tiny devices based on microfluidics could use bodily fluids to analyze and help treat tumors
Future Directions for Established Cancer Biomarkers
Catherine Crawford-Brown, MSc, MScComm
How new molecular tools and technologies are boosting the impact of existing biomarkers
Prenatal Diagnosis of Rare Diseases: The Dawn of Non-Invasive Methods
Suzanne Leech, PhD
Definitive prenatal diagnosis currently relies on invasive techniques, but that may be changing